Thus, ATP may be acting to allow inflammasome-activating TLR ligands (or other inflammasome activators) to enter the cell. Support for this idea comes from the fact that downregulation of Panx1 or inhibition of its binding to P2X7R

by an inhibitory peptide, 10Panx1, downregulates LPS in the presence of ATP induction of NLRP3 inflammasome activity 13. Another proposed mechanism is based on the fact that the ATP interaction Z-VAD-FMK purchase with P2X7R leads to K+ efflux; thus, ATP may be acting to cause an intracellular cation change necessary for inflammasome activation 14, 15. This idea is supported by the fact that inhibition of K+ efflux by increased extracellular K+ concentrations suppresses NLRP3 inflammasome activation 16, 17. When reconciling these two mechanisms, one should note that inhibition of K+ efflux does not affect Panx1 channel formation and that, conversely, 10Panx1 peptide Maraviroc in vitro inhibition of Panx1-mediated pore formation does not inhibit potassium efflux 12, 18. Thus, it is possible that channel formation and potassium efflux are independent functions of the P2X7R/Panx1 complex that are both necessary for NLRP3 inflammasome activation. In initial studies to determine why ATP is not necessary for inflammasome activation in R258W KI mice, it was found that the lack

of ATP dependence occurred in spite of inhibition of K+ efflux. Therefore, the mutation did not cause Clomifene a defect in the intracellular cation balance. In addition, there was no difference between KI and WT cells in their ability to generate endogenous extracellular ATP, hence the ATP independence was not the result of excessive ATP production from KI cells either 9. Further insight

into ATP function in R258W KI and WT cells came from studies of inflammasome activation (IL-1β release) in the presence of 10Panx1 peptide. We found that the presence of 10Panx1 decreased the inflammasome activity of WT cells by about 50% when added up to 4 h prior to the ATP pulse but had no effect on KI cells. This indicated that WT cells were dependent on the rapid Panx1 channel formation, whereas KI cells were not; however, residual inflammasome activation in WT cells in the presence of the Panx1 channel blockade was still dependent on the presence of ATP (perhaps acting via another cellular entry mechanism, depicted in Fig. 1 as the P2X7R/X channel). When 10Panx1 was added together with LPS (24 h prior to the ATP pulse), even the inflammasome activation of KI cells was substantially inhibited. This indicated that Panx1-mediated entry also occurs in KI cells, although that this route of entry is not absolutely critical as inflammasome activation occurs at least partially in the absence of ATP (perhaps due to LPS entry via other cellular mechanism; indicated as channel X in Fig. 1) 9.